M

    Medpace Holdings Inc (MEDP)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $593.99
    -6.66 (-1.11%)

    Market Cap: $16.77B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    93%(37/40)
    Avg Surprise
    +13.16%
    Streak
    12 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$4.44
    Range$4.31 - $4.69
    8 analysts
    EPS Revisions
    6
    0
    7d
    6
    1
    30d
    EPS Estimate Drift
    90d ago$4.28-3.5%
    60d ago$4.28-3.5%
    30d ago$4.28-3.5%
    7d ago$4.30-3.0%
    Current$4.44
    Revenue Consensus
    $714M
    Range$706M - $736M
    10 analysts
    Dec 31, 2026
    EPS Consensus$5.31
    Range$5.09 - $5.97
    10 analysts
    Revenue Consensus
    $751M
    Range$728M - $787M
    12 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$5.31---
    Sep 26EST
    		-$4.44---
    Jun 26
    		$4.25$4.08+4.17%Beat+37.1%
    Mar 26
    		$4.28$3.96+8.08%Beat+16.6%
    Dec 25
    		$4.67$4.18+11.72%Beat+26.9%
    Sep 25
    		$3.86$3.57+8.12%Beat+28.2%
    Jun 25
    		$3.10$3.00+3.33%Beat+12.3%
    Mar 25
    		$3.67$3.07+19.54%Beat+14.0%
    Dec 24
    		$3.68$3.12+18.12%Beat+49.6%
    Sep 24
    		$3.01$2.87+4.88%Beat+34.4%
    Jun 24
    		$2.76$2.63+4.94%Beat+41.5%
    Mar 24
    		$3.22$2.49+29.32%Beat+41.2%
    Dec 23
    		$2.46$2.22+10.81%Beat+16.0%
    Sep 23
    		$2.24$2.19+2.28%Beat+8.2%
    Jun 23
    		$1.95$2.00-2.50%Miss+31.8%
    Mar 23
    		$2.28$1.88+21.28%Beat+33.3%
    Dec 22
    		$2.12$1.79+18.44%Beat+60.6%
    Sep 22
    		$2.07$1.54+34.42%Beat+56.8%
    Jun 22
    		$1.48$1.39+6.47%Beat+35.8%
    Mar 22
    		$1.71$1.31+30.53%Beat+44.9%
    Dec 21
    		$1.32$1.25+5.60%Beat-2.2%
    Sep 21
    		$1.32$1.12+17.86%Beat+15.8%
    Jun 21
    		$1.09$1.03+5.83%Beat+60.3%
    Mar 21
    		$1.18$1.07+10.28%Beat+47.5%
    Dec 20
    		$1.35$1.24+8.87%Beat+58.8%
    Sep 20
    		$1.14$1.16-1.72%Miss+60.6%
    Jun 20
    		$0.68$0.44+54.55%Beat-16.0%
    Mar 20
    		$0.80$0.75+6.67%Beat+25.0%
    Dec 19
    		$0.85$0.75+13.33%Beat+11.8%
    Sep 19
    		$0.71$0.71+0.00%Beat+6.0%
    Jun 19
    		$0.81$0.64+26.56%Beat+32.8%
    Mar 19
    		$0.64$0.61+4.92%Beat+16.4%
    Dec 18
    		$0.76$0.67+13.43%Beat+94.9%
    Sep 18
    		$0.67$0.63+6.35%Beat+67.5%
    Jun 18
    		$0.61$0.43+41.86%Beat+60.5%
    Mar 18
    		$0.55$0.44+25.00%Beat+61.8%
    Dec 17
    		$0.39$0.38+2.63%Beat+11.4%
    Sep 17
    		$0.40$0.36+11.11%Beat+0.0%
    Jun 17
    		$0.38$0.30+26.67%Beat-
    Mar 17
    		$0.34$0.37-8.11%Miss-
    Dec 16
    		$0.35$0.34+2.94%Beat-
    Sep 16
    		$0.40$0.34+17.65%Beat-

    Key Metrics

    Valuation
    P/E Ratio34.82EV/EBITDA27.27x
    Price/FCF23.68xFCF Yield4.22%
    Profitability
    Profit Margin17.70%Operating Margin20.80%
    ROE162.10%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio0.73xQuick Ratio0.73x
    Trading Statistics
    Beta1.15Avg Volume206.83K
    52-Week High$677.9052-Week Low$373.00

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$609.13
    SMA 20$599.62
    SMA 50$566.08
    SMA 200$520.78
    EMA 10$604.90
    EMA 20$597.38
    EMA 50$566.07
    EMA 200$510.18

    MACD

    Line: 12.73Signal: 15.79Hist: -3.06

    ADX

    ADX: 36.7+DI: 24.1-DI: 19.0

    Aroon & PSAR

    Aroon Up76.0
    Aroon Down24.0
    PSAR$677.90

    Bollinger Bands

    Upper Band$627.92
    Lower Band$571.31
    %B Position944%(Upper)
    Band Width0.40

    RSI (14-Day)

    Neutral
    51.8

    Momentum Oscillators

    Stoch %K52.9
    Stoch %D65.0
    Williams %R-60.8
    ROC (10d)-0.5%
    Momentum-3.13
    CCI (20d)-40.1
    MFI (14d)38.8

    Volatility Measures

    ATR (14d)$18.89(3.2%)
    StdDev (20d)14.15
    Hist Vol25.5%(Moderate)

    Volume Flow

    VWAP$591.59
    OBV5.5M
    AD Line9.1M
    CMF (20d)0.175

    Volume Metrics

    Avg Vol (20d)204.7K
    Vol Ratio1.7x(High)
    VWMA (20d)$599.70

    Pivot Points

    R3$616.64
    R2$612.93
    R1$606.79
    Pivot Point$603.08
    S1$596.93
    S2$593.22
    S3$587.08

    Advanced Oscillators

    TSI20.31
    Ultimate Osc53.8
    KST79.45

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$707.33M$706.60M$708.45M$659.90M$603.31M$558.57M$536.59M$533.32M$528.10M$511.04M$498.40M$492.50M
    Cost of Revenue$0$0$503.13M$0$0$0$358.27M$0$0$0$361.60M$0
    Gross Profit$707.33M$706.60M$708.45M$659.90M$603.31M$558.57M$536.59M$533.32M$528.10M$511.04M$498.40M$492.50M
    Operating Expenses$560.51M$565.10M$555.18M$518.10M$476.98M$445.05M$411.21M$421.04M$422.95M$406.98M$411.08M$407.59M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$48.10M$47.92M$44.92M$48.08M$46.66M$57.90M$45.43M$49.22M$41.45M$44.08M$42.51M$41.41M
    Operating Income$146.82M$141.50M$153.27M$141.81M$126.33M$113.52M$125.38M$112.27M$105.15M$104.07M$87.32M$84.91M
    Interest Income$4.99M$5.12M$3.72M$1.52M$1.08M$6.46M$7.88M$7.53M$5.46M$4.12M$1.84M$-105,000
    Interest Expense$0$0$0$0$1.80M$0$0$0$0$0$0$1.71M
    Income Before Tax$151.66M$147.59M$156.83M$142.84M$124.54M$118.17M$133.88M$118.78M$110.48M$112.78M$90.71M$83.20M
    Income Tax Expense$30.30M$23.72M$21.70M$31.70M$34.28M$3.58M$16.86M$22.35M$22.13M$10.19M$12.41M$12.65M
    Net Income$121.36M$123.87M$135.13M$111.14M$90.26M$114.59M$117.02M$96.43M$88.35M$102.59M$78.30M$70.55M
    EBITDA$153.39M$149.38M$160.24M$148.37M$130.47M$118.64M$133.50M$118.77M$112.25M$115.65M$95.83M$90.18M
    EBIT$146.68M$142.47M$153.11M$141.32M$123.46M$111.71M$126.00M$111.25M$105.02M$108.66M$88.86M$83.31M
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about MEDP

    News

    Bronstein, Gewirtz & Grossman, LLC Is Investigating Medpace Holdings, Inc. (MEDP) And Encourages Stockholders to Connect

    Bronstein, Gewirtz & Grossman, LLC is investigating potential claims against Medpace Holdings, Inc. (NASDAQ: MEDP) for alleged corporate wrongdoing. The firm encourages Medpace investors who purchased securities before April 22, 2025, and still hold them, to join the investigation. Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning investors incur no out-of-pocket costs unless the firm is successful in recovering funds.

    ACCESS Newswire•8/25/26•
    Bearish

    Medpace (NASDAQ: MEDP) insider sells 15,978 shares in August trades

    Medpace Holdings, Inc. (NASDAQ: MEDP) President & CEO, August J. Troendle, sold a total of 15,978 shares of common stock in August 2026. These sales occurred on August 21 and August 24 at weighted average prices of $624.45 and $620.23 respectively, totaling approximately $9.97 million. Troendle also indirectly holds over 4.7 million shares through Medpace Investors, LLC.

    Stock Titan•8/25/26•
    Neutral

    Medpace Holdings Insider Sold Shares Worth $2,125,816, According to a Recent SEC Filing

    An insider at Medpace Holdings sold shares valued at $2,125,816, as reported in a recent SEC filing. This transaction follows other significant insider sales for the company in August. Medpace Holdings, a global clinical contract research organization, provides comprehensive clinical development services to the biotechnology, pharmaceutical, and medical device industries.

    www.marketscreener.com•8/25/26•
    Somewhat-Bearish

    MEDP - Why Medpace Outperforms Competitors in the Mid-Sized Biotech Niche

    Medpace Holdings (MEDP) is a clinical research organization (CRO) that specializes in serving small and mid-sized biopharma companies, handling the complex process of clinical trials from design to regulatory approval. The company's strength lies in its comprehensive expertise, global infrastructure, and integrated trial management system, which provides a competitive edge despite contract cancellability. While Medpace demonstrates strong financial quality with high margins and low capital expenditure, its current share price reflects a demanding valuation, indicating investors are already pricing in significant future growth.

    Simply Wall Street•8/25/26•
    Somewhat-Bullish

    Medpace (MEDP) CFO exercises options, sells 3,400 shares

    Medpace Holdings, Inc. (MEDP) CFO Kevin M. Brady exercised employee stock options to acquire 3,400 shares at $138.87 each and subsequently sold these 3,400 shares at $625.24 each on August 20, 2026. This transaction resulted in an approximate pre-tax spread of $1.65 million. Following the sale, Brady retained 3,403 employee stock options from the same grant, which had vested on February 15, 2026, and are set to expire on August 15, 2027.

    Stock Titan•8/24/26•
    Neutral

    Frequently Asked Questions About MEDP

    Does MEDP pay dividends?
    Medpace Holdings Inc (MEDP) does not currently pay a regular dividend.
    What is MEDP's P/E ratio?
    Medpace Holdings Inc has a price-to-earnings (P/E) ratio of 34.82.
    What is MEDP's market cap?
    Medpace Holdings Inc (MEDP) has a market capitalization of $16.77B with a current stock price of $593.99.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In